113 related articles for article (PubMed ID: 28987595)
21. Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes.
Irwin N; Frizelle P; Montgomery IA; Moffett RC; O'Harte FPM; Flatt PR
Diabetologia; 2012 Oct; 55(10):2747-2758. PubMed ID: 22814764
[TBL] [Abstract][Full Text] [Related]
22. Hepatic and cardiac beneficial effects of a long-acting Fc-apelin fusion protein in diet-induced obese mice.
Wang W; Zhang D; Yang R; Xia W; Qian K; Shi Z; Brown R; Zhou H; Xi Y; Shi L; Chen L; Xu F; Sun X; Zhu D; Gong DW
Diabetes Metab Res Rev; 2018 Jul; 34(5):e2997. PubMed ID: 29577579
[TBL] [Abstract][Full Text] [Related]
23. Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance.
Ojo OO; Srinivasan DK; Owolabi BO; Vasu S; Conlon JM; Flatt PR; Abdel-Wahab YH
PLoS One; 2015; 10(10):e0141549. PubMed ID: 26512980
[TBL] [Abstract][Full Text] [Related]
24. Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice.
Duparc T; Colom A; Cani PD; Massaly N; Rastrelli S; Drougard A; Le Gonidec S; Moulédous L; Frances B; Leclercq I; Llorens-Cortes C; Pospisilik JA; Delzenne NM; Valet P; Castan-Laurell I; Knauf C
Antioxid Redox Signal; 2011 Sep; 15(6):1477-96. PubMed ID: 21395477
[TBL] [Abstract][Full Text] [Related]
25. Apelin is a novel islet peptide.
Ringström C; Nitert MD; Bennet H; Fex M; Valet P; Rehfeld JF; Friis-Hansen L; Wierup N
Regul Pept; 2010 Jun; 162(1-3):44-51. PubMed ID: 20346374
[TBL] [Abstract][Full Text] [Related]
26. Eicosapentaenoic acid up-regulates apelin secretion and gene expression in 3T3-L1 adipocytes.
Lorente-Cebrián S; Bustos M; Marti A; Martinez JA; Moreno-Aliaga MJ
Mol Nutr Food Res; 2010 May; 54 Suppl 1():S104-11. PubMed ID: 20352620
[TBL] [Abstract][Full Text] [Related]
27. Apelin, a newly identified adipokine up-regulated by insulin and obesity.
Boucher J; Masri B; Daviaud D; Gesta S; Guigné C; Mazzucotelli A; Castan-Laurell I; Tack I; Knibiehler B; Carpéné C; Audigier Y; Saulnier-Blache JS; Valet P
Endocrinology; 2005 Apr; 146(4):1764-71. PubMed ID: 15677759
[TBL] [Abstract][Full Text] [Related]
28. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
Irwin N; Pathak V; Flatt PR
Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113
[TBL] [Abstract][Full Text] [Related]
29. Xenin-25[Lys13PAL]: a novel long-acting acylated analogue of xenin-25 with promising antidiabetic potential.
Gault VA; Martin CM; Flatt PR; Parthsarathy V; Irwin N
Acta Diabetol; 2015 Jun; 52(3):461-71. PubMed ID: 25374384
[TBL] [Abstract][Full Text] [Related]
30. Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats.
Pérez-Echarri N; Pérez-Matute P; Marcos-Gómez B; Martínez JA; Moreno-Aliaga MJ
Br J Nutr; 2009 Apr; 101(7):1059-67. PubMed ID: 18755047
[TBL] [Abstract][Full Text] [Related]
31. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.
Dray C; Knauf C; Daviaud D; Waget A; Boucher J; Buléon M; Cani PD; Attané C; Guigné C; Carpéné C; Burcelin R; Castan-Laurell I; Valet P
Cell Metab; 2008 Nov; 8(5):437-45. PubMed ID: 19046574
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
Irwin N; McClean PL; Flatt PR
J Pept Sci; 2007 Jun; 13(6):400-5. PubMed ID: 17486662
[TBL] [Abstract][Full Text] [Related]
33. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity.
Lee DK; George SR; O'Dowd BF
Trends Pharmacol Sci; 2006 Apr; 27(4):190-4. PubMed ID: 16530855
[TBL] [Abstract][Full Text] [Related]
34. Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity?
Bełtowski J
Med Sci Monit; 2006 Jun; 12(6):RA112-9. PubMed ID: 16733497
[TBL] [Abstract][Full Text] [Related]
35. Ontology of the apelinergic system in mouse pancreas during pregnancy and relationship with β-cell mass.
Strutt B; Szlapinski S; Gnaneswaran T; Donegan S; Hill J; Bennett J; Hill DJ
Sci Rep; 2021 Jul; 11(1):15475. PubMed ID: 34326390
[TBL] [Abstract][Full Text] [Related]
36. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.
O'Harte FP; Franklin ZJ; Irwin N
Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150
[TBL] [Abstract][Full Text] [Related]
37. Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle.
Yamamoto T; Habata Y; Matsumoto Y; Yasuhara Y; Hashimoto T; Hamajyo H; Anayama H; Fujii R; Fuse H; Shintani Y; Mori M
Biochim Biophys Acta; 2011 Sep; 1810(9):853-62. PubMed ID: 21609753
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
Green BD; Gault VA; O'Harte FP; Flatt PR
Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
[TBL] [Abstract][Full Text] [Related]
39. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
Miranville A; Herling AW; Biemer-Daub G; Voss MD
Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
[TBL] [Abstract][Full Text] [Related]
40. TNFalpha up-regulates apelin expression in human and mouse adipose tissue.
Daviaud D; Boucher J; Gesta S; Dray C; Guigne C; Quilliot D; Ayav A; Ziegler O; Carpene C; Saulnier-Blache JS; Valet P; Castan-Laurell I
FASEB J; 2006 Jul; 20(9):1528-30. PubMed ID: 16723381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
